Literature DB >> 1700751

T-T cell interactions are mediated by adhesion molecules.

S A Brod1, M Purvee, D Benjamin, D A Hafler.   

Abstract

The mechanism by which T cells signal other T cells is not well defined. This was investigated by studying the ability of circulating T cells to induce the proliferation of autologous T cell clones. Peripheral blood T cells activated by cross-linking of the CD3/T cell receptor complex, which increased the expression of cell adhesion molecules LFA-1, LFA-3 and ICAM-1, induced the proliferation of autologous T cell clones. Irradiated antigen-activated peripheral blood T cells could also induce the proliferation of T cell clones which could not recognize that antigen. T-T cell activation required cell contact, was not major histocompatibility complex (MHC) restricted and was blocked by monoclonal antibodies directed against adhesion molecules CD2 and LFA-3 but was not blocked by antibody to class II MHC determinants. As CD2 is the natural ligand for LFA-3, increased expression of T cell surface adhesion molecules LFA-1, ICAM-1 and particularly LFA-3 during an inflammatory response may rapidly recruit T cells that are activated through the CD2 pathway. These results allow a simplified model to explain how relatively few antigen/MHC-specific T cells can recruit large numbers of non-antigen-specific T cells in the generation of an inflammatory response and postulates a novel role of the CD2 molecule in T cell immune function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700751     DOI: 10.1002/eji.1830201015

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis.

Authors:  D A Hafler
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 2.  Tregs in T cell vaccination: exploring the regulation of regulation.

Authors:  Irun R Cohen; Francisco J Quintana; Avishai Mimran
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 3.  [Cellular therapy in autoimmune disease].

Authors:  K Thümmler; A Ramming; H Schulze-Koops; A Skapenko
Journal:  Z Rheumatol       Date:  2009-06       Impact factor: 1.372

4.  T-cell-mediated immunity to lymphocytic choriomeningitis virus in beta2-integrin (CD18)- and ICAM-1 (CD54)-deficient mice.

Authors:  J P Christensen; O Marker; A R Thomsen
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  A multimeric form of soluble recombinant sheep LFA-3 (CD58) inhibits human T-cell proliferation.

Authors:  K Yamashita; C R Parish; H S Warren; L C Harrison
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

Review 6.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

7.  T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones.

Authors:  K W Wucherpfennig; P Höllsberg; J H Richardson; D Benjamin; D A Hafler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway.

Authors:  J T Kimata; T J Palker; L Ratner
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture.

Authors:  J R Beauchamp; D J Abraham; G Bou-Gharios; T A Partridge; I Olsen
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

10.  Oligoclonal activation of CD4+ T lymphocytes in posterior uveitis.

Authors:  E J Feron; V L Calder; S L Lightman
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.